Molecular Pathology of Lung Cancer

2012
ISBN: 978-1-4614-3196-1
Verlag: Springer

Buch, Englisch, Band 6, 216 Seiten, Book, Format (B × H): 178 mm x 254 mm, Gewicht: 630 g

Reihe: Molecular Pathology Library

As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Cagle, Philip T.

Allen, Timothy Craig

Beasley, Mary Beth

Chirieac, Lucian R.

Dacic, Sanja

Borczuk, Alain C.

Kerr, Keith M.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pathologie, Cytopathologie, Histopathologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie Herz- & Thoraxchirurgie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

Section 1. Molecular Pathology of Lung Cancer: General PrinciplesCh. 1: Approach to Personalized Care of the Lung Cancer PatientPhilip T. CagleCh. 2: Etiology of Lung CancerPhilip T. CagleCh. 3: Genetic Susceptibility to Lung CancerTimothy Craig AllenCh. 4: Lung Cancer Stem CellsTimothy Craig AllenCh. 5: The Classification of Pre-Invasive LesionsKeith M. KerrCh. 6: Molecular Pathology of Precursor and Pre-Invasive Lesions Keith M. KerrCh. 7: Revised Classification for AdenocarcinomaPhilip T. CagleKeith M. KerrCh. 8: Molecular Basis for the Current Lung Cancer ClassificationAlain C. BorczukCh. 9: Molecular Diagnosis of Lung CancerLucian R. ChirieacPhilip T. CagleCh. 10: Molecular Targeted Therapy of Lung CancerSanja DacicCh. 11: Molecular Prognostic Markers of Lung CancerSanja DacicCh. 12: New Techniques for Optical and Molecular Visualization of Lung CancerPhilip T. CagleSection 2. Molecular Pathology of Lung Cancer: Specific Histologic TypesCh. 13: AdenocarcinomaKeith M. KerrCh. 14: Squamous Cell CarcinomaTimothy Craig AllenCh. 15: Molecular Pathology of Large Cell CarcinomaAlain C. BorczukCh. 16: Molecular Pathology of Small Cell CarcinomasMary Beth BeasleyCh. 17: Molecular Biopsy of Neuroendocrine Carcinomas Other Than Small CellCarcinomaMary Beth BeasleyCh. 18: Molecular Pathology of Uncommon CarcinomasAlain C. BorczukCh. 19: Biology of Lung Cancer MetastasesLucian R. Chirieac

Über Autor(innen)

Philip T. Cagle, MDThe Methodist Hospital, Houston, TX, USATimothy Craig Allen, MD, JDThe University of Texas Health Science Center at Tyler, TX, USAMary Beth Beasley, MDMount Sinai Medical Center, New York, NY, USALucian R. Chirieac, MDBrigham and Women’s Hospital, Boston, MA, USASanja Dacic, MD, PhDUniversity of Pittsburgh Medical Center, PA, USAAlain C. Borczuk, MDColumbia University Medical Center, New York, NY, USAKeith M. Kerr, MD, FRCPathAberdeen University Medical School, Scotland, UK